Gregory N. Dietsch - Concepedia

Concepedia

Author

Gregory N. Dietsch

EKOS Corporation

Also Known As

Dietsch, Gregory N., G N Dietsch, Gregory Dietsch, Gregory N Dietsch, Gregory N. Dietsch

46

Publications

1.8K

Citations

21

H-Index

44

Concepts

All Affiliations

EKOS Corporation University of Washington Johns Hopkins University Fred Hutch Cancer Center Kindeva Drug Delivery (United States)

GN

About

Gregory N. Dietsch is an author at EKOS Corporation specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	848
2	Immunology	9	9	718
3	Cell Biology	4	4	129
4	Allergy	2	2	433
5	Allergy Medicine	1	1	356

Gregory N. Dietsch

×

24

Publications

1.8K

Citations

21

H-Index

	Year	Citations
Chemokine expression in murine experimental allergic encephalomyelitis Ronald Godiska, David Chantry, Gregory N. Dietsch, Journal of Neuroimmunology AllergyAllergy MedicineImmunologyAutoimmunityChemokine Expression	1995	356
VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC Hailing Lu, Gregory N. Dietsch, Maura-Ann H. Matthews, Clinical Cancer Research	2011	170
The Role of Recombinant Platelet-Activating Factor Acetylhydrolase in a Neonatal Rat Model of Necrotizing Enterocolitis Michael S. Caplan, Matthew Lickerman, Luba Adler, Pediatric Research InflammationMedicinePathogenesisPathologyNecrotizing Enterocolitis	1997	130
Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN Laura Q.M. Chow, Chihiro Morishima, Keith D. Eaton, Clinical Cancer Research	2016	125
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck Robert L. Ferris, Nabil F. Saba, Barbara J. Gitlitz, JAMA Oncology	2018	108
Inhibition of Experimental Vasospasm With Anti–Intercellular Adhesion Molecule-1 Monoclonal Antibody in Rats Eric M. Oshiro, Patricia Hoffman, Gregory N. Dietsch, Stroke	1997	97
Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates Richard E. Clatterbuck, Philippe Gailloud, Lynn Ogata, Journal of neurosurgery	2003	79
Recombinant Human Platelet-Activating Factor- Acetylhydrolase Inhibits Airway Inflammation and Hyperreactivity in Mouse Asthma Model William R. Henderson, Jiangyang Lu, Karen M. Poole, The Journal of Immunology InflammationAsthmaAnti-inflammatoryAllergyInflammatory Lung Disease	2000	77
TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells Ryan Stephenson, Chwee Ming Lim, Maura Matthews, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceNeck Cancer CellsMedicineTlr8 StimulationT-regulatory Cell	2013	71
Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity Gregory N. Dietsch, Hailing Lu, Yi Yang, PLoS ONE	2016	66

Page 1